{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:34:07Z","timestamp":1792596847799,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11357-022-00513-7","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T22:02:44Z","timestamp":1642284164000},"page":"2025-2045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac troponin T and autoimmunity in skeletal muscle aging"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-1134","authenticated-orcid":false,"given":"Tan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zherong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy M.","family":"Cawthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nicklas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kritchevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"5","key":"513_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1532-5415.2000.tb04994.x","volume":"48","author":"M Hirvensalo","year":"2000","unstructured":"Hirvensalo M, Rantanen T, Heikkinen E. Mobility difficulties and physical activity as predictors of mortality and loss of independence in the community-living older population. J Am Geriatr Soc. 2000;48(5):493\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"513_CR2","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2105\/AJPH.72.12.1373","volume":"72","author":"LG Branch","year":"1982","unstructured":"Branch LG, Jette AM. A prospective-study of long-term care institutionalization among the aged. Am J Public Health. 1982;72(12):1373\u20139.","journal-title":"Am J Public Health"},{"issue":"6","key":"513_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1212\/01.WNL.0000068529.36993.03","volume":"61","author":"SA Muley","year":"2003","unstructured":"Muley SA, Day JW. Autoimmune rippling muscle. Neurology. 2003;61(6):869\u201370.","journal-title":"Neurology"},{"issue":"6","key":"513_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mus.880180609","volume":"18","author":"RG Smith","year":"1995","unstructured":"Smith RG, et al. Altered muscle calcium-channel binding-kinetics in autoimmune motoneuron disease. Muscle Nerve. 1995;18(6):620\u20137.","journal-title":"Muscle Nerve"},{"issue":"2","key":"513_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0304-3991(87)90199-9","volume":"23","author":"R Ludatscher","year":"1987","unstructured":"Ludatscher R, Lichtig C. The muscle capillaries basement-membrane in autoimmune-diseases. Ultramicroscopy. 1987;23(2):243\u2013243.","journal-title":"Ultramicroscopy"},{"issue":"5","key":"513_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","volume":"18","author":"A Vincent","year":"2005","unstructured":"Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol. 2005;18(5):519\u201325.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"513_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mus.1218","volume":"25","author":"Y Liyanage","year":"2002","unstructured":"Liyanage Y, et al. The agrin\/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve. 2002;25(1):4\u201316.","journal-title":"Muscle Nerve"},{"key":"513_CR8","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/j.nmd.2016.06.425","volume":"26","author":"A Guttsches","year":"2016","unstructured":"Guttsches A, et al. Autoimmune rippling muscle disease: IgG antibodies bind to human muscle fibers. Neuromuscul Disord. 2016;26:S203\u2013S203.","journal-title":"Neuromuscul Disord"},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","volume":"77","author":"I Koneczny","year":"2017","unstructured":"Koneczny I, et al. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. J Autoimmun. 2017;77:104\u201315.","journal-title":"J Autoimmun"},{"issue":"7","key":"513_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/ndt\/13.7.1825","volume":"13","author":"T Rott","year":"1998","unstructured":"Rott T, et al. IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant. 1998;13(7):1825\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/aws025","volume":"135","author":"R Klooster","year":"2012","unstructured":"Klooster R, et al. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain. 2012;135:1081\u2013101.","journal-title":"Brain"},{"issue":"51","key":"513_CR12","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","volume":"110","author":"MG Huijbers","year":"2013","unstructured":"Huijbers MG, et al. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci USA. 2013;110(51):20783\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"207","key":"513_CR13","first-page":"297","volume":"52","author":"DA Isenberg","year":"1983","unstructured":"Isenberg DA. Immunoglobulin deposition in skeletal-muscle in primary muscle disease. Quarterly Journal of Medicine. 1983;52(207):297\u2013310.","journal-title":"Quarterly Journal of Medicine"},{"issue":"3","key":"513_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1469-8749.1998.tb15448.x","volume":"40","author":"J Newsom-Davis","year":"1998","unstructured":"Newsom-Davis J. Autoimmune and genetic disorders at the neuromuscular junction. The 1997 Ronnie Mac Keith lecture. Dev Med Child Neurol. 1998;40(3):199\u2013206.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"513_CR15","doi-asserted-by":"publisher","first-page":"A30","DOI":"10.1096\/fasebj.20.4.A30-a","volume":"20","author":"B Voss","year":"2006","unstructured":"Voss B, et al. Target proteins in human autoimmune rippling muscle disease. FASEB J. 2006;20(4):A30\u2013A30.","journal-title":"FASEB J"},{"issue":"3","key":"513_CR16","first-page":"S94","volume":"52","author":"YH Bai","year":"2002","unstructured":"Bai YH, Pachner AR, Cadavid D. Immunoglobulin deposition and inflammation in skeletal muscle in the nonhuman primate model of Lyme borreliosis. Ann Neurol. 2002;52(3):S94\u2013S94.","journal-title":"Ann Neurol"},{"issue":"6","key":"513_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1159\/000330031","volume":"20","author":"E Tuzun","year":"2011","unstructured":"Tuzun E, et al. Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients. Med Princ Pract. 2011;20(6):581\u20133.","journal-title":"Med Princ Pract"},{"issue":"11","key":"513_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","volume":"66","author":"S Suzuki","year":"2009","unstructured":"Suzuki S, et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol. 2009;66(11):1334\u20138.","journal-title":"Arch Neurol"},{"issue":"6","key":"513_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","volume":"14","author":"F Romi","year":"2007","unstructured":"Romi F, Aarli JA, Gilhus NE. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. Eur J Neurol. 2007;14(6):617\u201320.","journal-title":"Eur J Neurol"},{"key":"513_CR20","first-page":"546","volume":"841","author":"M Rimer","year":"1998","unstructured":"Rimer M. Agrin-induced aggregation of acetylcholine receptors in muscles of rats with experimental autoimmune myasthenia gravis. Myasthenia Gravis Relat Dis. 1998;841:546\u20139.","journal-title":"Myasthenia Gravis Relat Dis"},{"issue":"2","key":"513_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/jaut.1996.0021","volume":"9","author":"JM Heckmann","year":"1996","unstructured":"Heckmann JM, et al. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimmun. 1996;9(2):175\u201380.","journal-title":"J Autoimmun"},{"issue":"2","key":"513_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.139.2.375","volume":"139","author":"V Straub","year":"1997","unstructured":"Straub V, et al. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 1997;139(2):375\u201385.","journal-title":"J Cell Biol"},{"issue":"6","key":"513_CR23","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.ajpath.2015.02.020","volume":"185","author":"JA Roche","year":"2015","unstructured":"Roche JA, et al. Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A\/J mouse skeletal muscle. Am J Pathol. 2015;185(6):1686\u201398.","journal-title":"Am J Pathol"},{"issue":"5","key":"513_CR24","first-page":"640","volume":"72","author":"DC Hughes","year":"2017","unstructured":"Hughes DC, et al. Age-related differences in dystrophin: impact on force transfer proteins, membrane integrity, and neuromuscular junction stability. J Gerontol A Biol Sci Med Sci. 2017;72(5):640\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"513_CR25","doi-asserted-by":"crossref","unstructured":"Morgan JE, et al. Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat Commun. 2018;9(1):3655.","DOI":"10.1038\/s41467-018-06057-9"},{"issue":"45","key":"513_CR26","doi-asserted-by":"publisher","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","volume":"114","author":"A Schreiber","year":"2017","unstructured":"Schreiber A, et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc Natl Acad Sci USA. 2017;114(45):E9618\u201325.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"513_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000478012","volume":"63","author":"A Watad","year":"2017","unstructured":"Watad A, et al. Autoimmunity in the elderly: insights from basic science and clinics - a mini-review. Gerontology. 2017;63(6):515\u201323.","journal-title":"Gerontology"},{"issue":"2","key":"513_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.autrev.2005.09.008","volume":"5","author":"M Prelog","year":"2006","unstructured":"Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev. 2006;5(2):136\u20139.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"513_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0047-6374(92)90071-K","volume":"66","author":"GE Degreef","year":"1992","unstructured":"Degreef GE, et al. Serum immunoglobulin class and Igg subclass levels and the occurrence of homogeneous immunoglobulins during the course of aging in humans. Mech Ageing Dev. 1992;66(1):29\u201344.","journal-title":"Mech Ageing Dev"},{"key":"513_CR30","first-page":"487","volume":"1089","author":"F Listi","year":"2006","unstructured":"Listi F, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Estrogens Hum Dis. 2006;1089:487\u201395.","journal-title":"Estrogens Hum Dis"},{"issue":"2","key":"513_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0167-4943(84)90009-8","volume":"3","author":"G Batory","year":"1984","unstructured":"Batory G, et al. Antibody and immunoglobulin levels in aged humans. Arch Gerontol Geriatr. 1984;3(2):175\u201388.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"513_CR32","first-page":"84","volume":"22","author":"J Radl","year":"1975","unstructured":"Radl J, et al. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol. 1975;22(1):84\u201390.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"513_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41467-021-20918-w","volume":"12","author":"G Jones","year":"2021","unstructured":"Jones G, et al. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021;12(1):654.","journal-title":"Nat Commun"},{"issue":"6","key":"513_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1023\/A:1005397501968","volume":"19","author":"SV Perry","year":"1998","unstructured":"Perry SV. Troponin T: genetics, properties and function. J Muscle Res Cell Motil. 1998;19(6):575\u2013602.","journal-title":"J Muscle Res Cell Motil"},{"issue":"5\u20136","key":"513_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2006.12.008","volume":"40","author":"S Fredericks","year":"2007","unstructured":"Fredericks S, et al. Effect of denervation on the content of cardiac troponin-T and cardiac troponin-I in rat skeletal muscle. Clin Biochem. 2007;40(5\u20136):423\u20136.","journal-title":"Clin Biochem"},{"issue":"2","key":"513_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1242\/dev.110.2.547","volume":"110","author":"L Saggin","year":"1990","unstructured":"Saggin L, et al. Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. Development. 1990;110(2):547\u201354.","journal-title":"Development"},{"issue":"17","key":"513_CR37","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","volume":"58","author":"AS Jaffe","year":"2011","unstructured":"Jaffe AS, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58(17):1819\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"513_CR38","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2014.03.027","volume":"63","author":"D Rittoo","year":"2014","unstructured":"Rittoo D, et al. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases. J Am Coll Cardiol. 2014;63(22):2411\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"513_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.201402079","volume":"207","author":"S Dadgar","year":"2014","unstructured":"Dadgar S, et al. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. J Cell Biol. 2014;207(1):139\u201358.","journal-title":"J Cell Biol"},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/brain\/awl023","volume":"129","author":"M Bakay","year":"2006","unstructured":"Bakay M, et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain. 2006;129:996\u20131013.","journal-title":"Brain"},{"issue":"10","key":"513_CR41","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1152\/japplphysiol.00435.2011","volume":"112","author":"U Raue","year":"2012","unstructured":"Raue U, et al. Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J Appl Physiol (1985). 2012;112(10):1625\u201336.","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"513_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcsm.12204","volume":"8","author":"ZR Xu","year":"2017","unstructured":"Xu ZR, et al. Cardiac troponin T and fast skeletal muscle denervation in ageing. J Cachexia Sarcopenia Muscle. 2017;8(5):808\u201323.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"513_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1373\/clinchem.2009.138099","volume":"56","author":"M Adamczyk","year":"2010","unstructured":"Adamczyk M, Brashear RJ, Mattingly PG. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem. 2010;56(4):676\u20137.","journal-title":"Clin Chem"},{"issue":"8","key":"513_CR44","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1373\/clinchem.2009.125781","volume":"55","author":"M Adamczyk","year":"2009","unstructured":"Adamczyk M, Brashear RJ, Mattingly PG. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem. 2009;55(8):1592\u20133.","journal-title":"Clin Chem"},{"issue":"35","key":"513_CR45","doi-asserted-by":"publisher","first-page":"29753","DOI":"10.1074\/jbc.M112.373191","volume":"287","author":"HZ Feng","year":"2012","unstructured":"Feng HZ, et al. Toad heart utilizes exclusively slow skeletal muscle troponin T an evolutionary adaptation with potential functional benefits. J Biol Chem. 2012;287(35):29753\u201364.","journal-title":"J Biol Chem"},{"issue":"12","key":"513_CR46","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/gerona\/glt204","volume":"69","author":"T Zhang","year":"2014","unstructured":"Zhang T, et al. Human slow troponin T (TNNT1) Pre-mRNA Alternative Splicing Is an Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults. J Gerontol A Biol Sci Med Sci. 2014;69(12):1437\u201347.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"513_CR47","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3945\/ajcn.114.105270","volume":"101","author":"BJ Nicklas","year":"2015","unstructured":"Nicklas BJ, et al. Effects of resistance training with and without caloric restriction on physical function and mobility in overweight and obese older adults: a randomized controlled trial. Am J Clin Nutr. 2015;101(5):991\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"513_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12603-015-0438-7","volume":"19","author":"KM Beavers","year":"2015","unstructured":"Beavers KM, et al. Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: a pilot feeding study. J Nutr Health Aging. 2015;19(1):87\u201395.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"513_CR49","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94.","journal-title":"J Gerontol"},{"issue":"3","key":"513_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000091824","volume":"52","author":"HJ Martin","year":"2006","unstructured":"Martin HJ, et al. Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? A comparison with the gold standard Bodex dynamometry. Gerontology. 2006;52(3):154\u20139.","journal-title":"Gerontology"},{"issue":"1","key":"513_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2044-5040-2-8","volume":"2","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ, et al. Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting. Skelet Muscle. 2012;2(1):8.","journal-title":"Skelet Muscle"},{"issue":"1","key":"513_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen L, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13(1):133\u201340.","journal-title":"Nat Neurosci"},{"issue":"1","key":"513_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","volume":"89","author":"DS Sohal","year":"2001","unstructured":"Sohal DS, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89(1):20\u20135.","journal-title":"Circ Res"},{"issue":"4","key":"513_CR54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"278","key":"513_CR55","doi-asserted-by":"publisher","first-page":"278ra32","DOI":"10.1126\/scitranslmed.3010283","volume":"7","author":"DC Files","year":"2015","unstructured":"Files DC, et al. Therapeutic exercise attenuates neutrophilic lung injury and skeletal muscle wasting. Sci Transl Med. 2015;7(278):278ra32.","journal-title":"Sci Transl Med"},{"issue":"6203","key":"513_CR56","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1126\/science.1250744","volume":"345","author":"S Arimura","year":"2014","unstructured":"Arimura S, et al. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Science. 2014;345(6203):1505\u20138.","journal-title":"Science"},{"issue":"5","key":"513_CR57","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcsm.12204","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, et al. Cardiac troponin T and fast skeletal muscle denervation in ageing. J Cachexia Sarcopenia Muscle. 2017;8(5):808\u201323.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"513_CR58","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/gerona\/glt032","volume":"68","author":"TG Graber","year":"2013","unstructured":"Graber TG, et al. C57BL\/6 neuromuscular healthspan scoring system. J Gerontol A Biol Sci Med Sci. 2013;68(11):1326\u201336.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"513_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jss.2015.02.011","volume":"196","author":"P Koutakis","year":"2015","unstructured":"Koutakis P, et al. Abnormal myofiber morphology and limb dysfunction in claudication. J Surg Res. 2015;196(1):172\u20139.","journal-title":"J Surg Res"},{"issue":"1","key":"513_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00353-1","volume":"31","author":"L Schaeffer","year":"2001","unstructured":"Schaeffer L, de Kerchoved\u2019Exaerde A, Changeux JP. Targeting transcription to the neuromuscular synapse. Neuron. 2001;31(1):15\u201322.","journal-title":"Neuron"},{"key":"513_CR61","first-page":"53","volume":"998","author":"A Mejat","year":"2003","unstructured":"Mejat A, et al. Synapse-specific gene expression at the neuromuscular junction. Myasthenia Gravis andRelated Disorders. 2003;998:53\u201365.","journal-title":"Myasthenia Gravis andRelated Disorders."},{"issue":"2","key":"513_CR62","first-page":"1136","volume":"15","author":"XJ Zhu","year":"1995","unstructured":"Zhu XJ, Yeadon JE, Burden SJ. Aml1 is expressed in skeletal-muscle and is regulated by innervation (Vol 14, Pg 8056, 1994). Mol Cell Biol. 1995;15(2):1136\u20131136.","journal-title":"Mol Cell Biol"},{"issue":"14","key":"513_CR63","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1101\/gad.1318305","volume":"19","author":"XX Wang","year":"2005","unstructured":"Wang XX, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev. 2005;19(14):1715\u201322.","journal-title":"Genes Dev"},{"issue":"15","key":"513_CR64","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1212\/WNL.0000000000007260","volume":"92","author":"A Pestronk","year":"2019","unstructured":"Pestronk A, et al. Immune myopathy with large histiocyte-related myofiber necrosis. Neurology. 2019;92(15):e1763\u201372.","journal-title":"Neurology"},{"issue":"2","key":"513_CR65","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/rej.2008.0664","volume":"11","author":"G Colonna-Romano","year":"2008","unstructured":"Colonna-Romano G, et al. B cell immunosenescence in the elderly and in centenarians. Rejuvenation Res. 2008;11(2):433\u20139.","journal-title":"Rejuvenation Res"},{"issue":"25","key":"513_CR66","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330(25):1797\u2013810.","journal-title":"N Engl J Med"},{"issue":"10","key":"513_CR67","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2(10):797\u2013804.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"513_CR68","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.20061","volume":"55","author":"J McConville","year":"2004","unstructured":"McConville J, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004;55(4):580\u20134.","journal-title":"Ann Neurol"},{"issue":"2","key":"513_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ana.20341","volume":"57","author":"H Shiraishi","year":"2005","unstructured":"Shiraishi H, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol. 2005;57(2):289\u201393.","journal-title":"Ann Neurol"},{"key":"513_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","volume":"8","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ, et al. Mechanisms of autoantibody-induced pathology. Front Immunol. 2017;8:603.","journal-title":"Front Immunol"},{"key":"513_CR71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06808.x","volume":"1275","author":"JJ Plomp","year":"2012","unstructured":"Plomp JJ, et al. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Ann N Y AcadSci. 2012;1275:114\u201322.","journal-title":"Ann N Y AcadSci."},{"issue":"6","key":"513_CR72","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2012.03.047","volume":"149","author":"AT Naito","year":"2012","unstructured":"Naito AT, et al. Complement C1q activates canonical wnt signaling and promotes aging-related phenotypes. Cell. 2012;149(6):1298\u2013313.","journal-title":"Cell"},{"issue":"3","key":"513_CR73","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1096\/fj.14-262154","volume":"29","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, et al. Serum C1q as a novel biomarker of sarcopenia in older adults. FASEB J. 2015;29(3):1003\u201310.","journal-title":"FASEB J"},{"issue":"6","key":"513_CR74","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479\u201392.","journal-title":"Semin Nephrol"},{"issue":"1","key":"513_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","volume":"274","author":"D Ricklin","year":"2016","unstructured":"Ricklin D, et al. Complement component C3-The \u201cSwiss Army Knife\u201d of innate immunity and host defense. Immunol Rev. 2016;274(1):33\u201358.","journal-title":"Immunol Rev"},{"key":"513_CR76","first-page":"127","volume":"1274","author":"LL Kusner","year":"2012","unstructured":"Kusner LL, Kaminski HJ. The role of complement in experimental autoimmune myasthenia gravis. Myasthenia Gravis Relat Disord I. 2012;1274:127\u201332.","journal-title":"Myasthenia Gravis Relat Disord I"},{"issue":"2","key":"513_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","volume":"2","author":"PN Nesargikar","year":"2012","unstructured":"Nesargikar PN, Spiller B, Chavez R. The complement system: history, pathways, cascade and inhibitors. Eur J Microbiol Immunol (Bp). 2012;2(2):103\u201311.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"513_CR78","doi-asserted-by":"publisher","first-page":"118370","DOI":"10.1016\/j.lfs.2020.118370","volume":"260","author":"X Wu","year":"2020","unstructured":"Wu X, et al. Complement C3 deficiency ameliorates aging related changes in the kidney. Life Sci. 2020;260:118370.","journal-title":"Life Sci"},{"issue":"38","key":"513_CR79","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","volume":"35","author":"Q Shi","year":"2015","unstructured":"Shi Q, et al. Complement C3-deficient mice fail to display age-related hippocampal decline. J Neurosci. 2015;35(38):13029\u201342.","journal-title":"J Neurosci"},{"issue":"12","key":"513_CR80","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1172\/JCI42390","volume":"120","author":"R Han","year":"2010","unstructured":"Han R, et al. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Investig. 2010;120(12):4366\u201374.","journal-title":"J Clin Investig"},{"issue":"6","key":"513_CR81","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.devcel.2014.02.009","volume":"28","author":"JY Wang","year":"2014","unstructured":"Wang JY, et al. Caspase-3 cleavage of dishevelled induces elimination of postsynaptic structures. Dev Cell. 2014;28(6):670\u201384.","journal-title":"Dev Cell"},{"issue":"1","key":"513_CR82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/hmg\/ddt397","volume":"23","author":"HP Zhu","year":"2014","unstructured":"Zhu HP, Pytel P, Gomez CM. Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Hum Mol Genet. 2014;23(1):69\u201377.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"513_CR83","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/S0002-9440(10)65081-X","volume":"156","author":"J Frenette","year":"2000","unstructured":"Frenette J, Cai BY, Tidball JG. Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol. 2000;156(6):2103\u201310.","journal-title":"Am J Pathol"},{"issue":"4","key":"513_CR84","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10495-015-1091-7","volume":"20","author":"H Shi","year":"2015","unstructured":"Shi H, et al. Exposure to the complement C5b\u20139 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis. Apoptosis. 2015;20(4):433\u201343.","journal-title":"Apoptosis"},{"key":"513_CR85","first-page":"402783","volume":"2012","author":"AM Carter","year":"2012","unstructured":"Carter AM. Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica (Cairo). 2012;2012:402783.","journal-title":"Scientifica (Cairo)"},{"key":"513_CR86","doi-asserted-by":"crossref","unstructured":"Liu ZF, et al. Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study. Sci Rep. 2016;6:18713.","DOI":"10.1038\/srep18713"},{"issue":"2","key":"513_CR87","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2249.2006.03198.x","volume":"146","author":"J Chamberlain-Banoub","year":"2006","unstructured":"Chamberlain-Banoub J, et al. Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats. Clin Exp Immunol. 2006;146(2):278\u201386.","journal-title":"Clin Exp Immunol"},{"key":"513_CR88","doi-asserted-by":"crossref","unstructured":"El Idrissi NB, et al. Complement activation at the motor end-plates in amyotrophic lateral sclerosis.\u00a0J Neuroinflammation. 2016;13(1):72.","DOI":"10.1186\/s12974-016-0538-2"},{"issue":"1\u20132","key":"513_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","volume":"264","author":"A Rojana-udomsart","year":"2013","unstructured":"Rojana-udomsart A, et al. Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). J Neuroimmunol. 2013;264(1\u20132):65\u201370.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"513_CR90","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmet.2020.07.001","volume":"32","author":"T Alissafi","year":"2020","unstructured":"Alissafi T, et al. Mitochondrial oxidative damage underlies regulatory T cell defects in autoimmunity. Cell Metab. 2020;32(4):591-604.e7.","journal-title":"Cell Metab"},{"key":"513_CR91","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1749-6632.1987.tb51301.x","volume":"505","author":"AG Engel","year":"1987","unstructured":"Engel AG, Arahata K. The membrane attack complex of complement at the endplate in myasthenia-gravis. Ann N Y Acad Sci. 1987;505:326\u201332.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"513_CR92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/cm.21095","volume":"70","author":"T Zhang","year":"2013","unstructured":"Zhang T, Birbrair A, Delbono O. Nonmyofilament-associated troponin T3 nuclear and nucleolar localization sequence and leucine zipper domain mediate muscle cell apoptosis. Cytoskeleton (Hoboken). 2013;70(3):134\u201347.","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"1","key":"513_CR93","doi-asserted-by":"publisher","first-page":"H283","DOI":"10.1152\/ajpheart.01200.2008","volume":"297","author":"EM Jeong","year":"2009","unstructured":"Jeong EM, et al. Nonmyofilament-associated troponin T fragments induce apoptosis. Am J Physiol Heart Circ Physiol. 2009;297(1):H283\u201392.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"513_CR94","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1074\/jbc.M110.148684","volume":"286","author":"CA Sumandea","year":"2011","unstructured":"Sumandea CA, et al. Cardiac troponin T, a sarcomeric AKAP, tethers protein kinase A at the myofilaments. J Biol Chem. 2011;286(1):530\u201341.","journal-title":"J Biol Chem"},{"key":"513_CR95","doi-asserted-by":"crossref","unstructured":"Chai RJ, et al. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. Plos One. 2011;6(12).","DOI":"10.1371\/journal.pone.0028090"},{"key":"513_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1113\/jphysiol.1988.sp017279","volume":"404","author":"SV Brooks","year":"1988","unstructured":"Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol. 1988;404:71\u201382.","journal-title":"J Physiol"},{"issue":"Pt 2","key":"513_CR97","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","volume":"535","author":"GS Lynch","year":"2001","unstructured":"Lynch GS, et al. Force and power output of fast and slow skeletal muscles from mdx mice 6\u201328 months old. J Physiol. 2001;535(Pt 2):591\u2013600.","journal-title":"J Physiol"},{"issue":"8","key":"513_CR98","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.exger.2012.05.007","volume":"47","author":"X Feng","year":"2012","unstructured":"Feng X, et al. Myosin heavy chain isoform expression in the Vastus Lateralis muscle of aging African green vervet monkeys. Exp Gerontol. 2012;47(8):601\u20137.","journal-title":"Exp Gerontol"},{"key":"513_CR99","doi-asserted-by":"crossref","unstructured":"Valdez G, et al. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One. 2012;7(4):e34640.","DOI":"10.1371\/journal.pone.0034640"},{"issue":"10","key":"513_CR100","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","volume":"45","author":"S Ciciliot","year":"2013","unstructured":"Ciciliot S, et al. Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol. 2013;45(10):2191\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"513_CR101","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","volume":"48","author":"R Nilwik","year":"2013","unstructured":"Nilwik R, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013;48(5):492\u20138.","journal-title":"Exp Gerontol"},{"issue":"1\u20132","key":"513_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-5728(00)00394-5","volume":"111","author":"F Romi","year":"2000","unstructured":"Romi F, et al. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis - a study of IgG subclasses and clinical correlations. J Neuroimmunol. 2000;111(1\u20132):169\u201376.","journal-title":"J Neuroimmunol"},{"issue":"22","key":"513_CR103","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","volume":"82","author":"C Gasperi","year":"2014","unstructured":"Gasperi C, et al. Anti-agrin autoantibodies in myasthenia gravis. Neurology. 2014;82(22):1976\u201383.","journal-title":"Neurology"},{"issue":"5","key":"513_CR104","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.exger.2010.03.007","volume":"45","author":"MR Deschenes","year":"2010","unstructured":"Deschenes MR, et al. Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers. Exp Gerontol. 2010;45(5):389\u201393.","journal-title":"Exp Gerontol"},{"issue":"1","key":"513_CR105","doi-asserted-by":"publisher","first-page":"e29082","DOI":"10.1371\/journal.pone.0029082","volume":"7","author":"SL Rowan","year":"2012","unstructured":"Rowan SL, et al. Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle. PLoS One. 2012;7(1):e29082.","journal-title":"PLoS One"},{"issue":"1","key":"513_CR106","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exger.2012.05.021","volume":"48","author":"M Drey","year":"2013","unstructured":"Drey M, et al. C-terminal agrin fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol. 2013;48(1):76\u201380.","journal-title":"Exp Gerontol"},{"issue":"12","key":"513_CR107","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/gerona\/glab139","volume":"76","author":"J Pratt","year":"2021","unstructured":"Pratt J, et al. Plasma C-terminal agrin fragment as an early biomarker for sarcopenia: results from the GenoFit study. J Gerontol A Biol Sci Med Sci. 2021;76(12):2090\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"513_CR108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.exger.2012.03.002","volume":"48","author":"S Hettwer","year":"2013","unstructured":"Hettwer S, et al. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients. Exp Gerontol. 2013;48(1):69\u201375.","journal-title":"Exp Gerontol"},{"issue":"16","key":"513_CR109","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","volume":"135","author":"SL Seliger","year":"2017","unstructured":"Seliger SL, et al. High-sensitive cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure MESA (Multi-Ethnic Study of Atherosclerosis). Circulation. 2017;135(16):1494\u2013505.","journal-title":"Circulation"},{"key":"513_CR110","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.archger.2016.03.010","volume":"65","author":"SJ Zhang","year":"2016","unstructured":"Zhang SJ, et al. High-sensitivity cardiac troponin T in geriatric inpatients. Arch Gerontol Geriatr. 2016;65:111\u20135.","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"513_CR111","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/NNR.0000000000000018","volume":"63","author":"EL Abreu","year":"2014","unstructured":"Abreu EL, et al. Skeletal muscle troponin as a novel biomarker to enhance assessment of the impact of strength training on fall prevention in the older adults. Nurs Res. 2014;63(2):75\u201382.","journal-title":"Nurs Res"},{"issue":"1","key":"513_CR112","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jcb.20857","volume":"99","author":"TC Watkins","year":"2006","unstructured":"Watkins TC, et al. Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients. J Cell Biochem. 2006;99(1):79\u201387.","journal-title":"J Cell Biochem"},{"issue":"3","key":"513_CR113","first-page":"115","volume":"7","author":"Z Jadali","year":"2008","unstructured":"Jadali Z, Sanati MH. The autoimmune diseases manifested by production of autoantibodies: the autoantigens identified by random peptide library. Iran J Allergy Asthma Immunol. 2008;7(3):115\u201331.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"513_CR114","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2009.02.037","volume":"281","author":"KJ Wang","year":"2009","unstructured":"Wang KJ, et al. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. Cancer Lett. 2009;281(2):144\u201350.","journal-title":"Cancer Lett"},{"issue":"5","key":"513_CR115","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12185-017-2287-0","volume":"106","author":"S Hao","year":"2017","unstructured":"Hao S, et al. Screening novel autoantigens targeted by serum IgG autoantibodies in immunorelated pancytopenia by SEREX. Int J Hematol. 2017;106(5):622\u201330.","journal-title":"Int J Hematol"},{"issue":"16","key":"513_CR116","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.106.635664","volume":"114","author":"S Goser","year":"2006","unstructured":"Goser S, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation. 2006;114(16):1693\u2013702.","journal-title":"Circulation"},{"issue":"3","key":"513_CR117","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1373\/clinchem.2012.194860","volume":"59","author":"T Savukoski","year":"2013","unstructured":"Savukoski T, et al. Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin. Clin Chem. 2013;59(3):512\u20138.","journal-title":"Clin Chem"},{"issue":"1","key":"513_CR118","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1373\/clinchem.2016.261602","volume":"63","author":"AV Vylegzhanina","year":"2017","unstructured":"Vylegzhanina AV, et al. Anti-cardiac troponin autoantibodies are specific to the conformational epitopes formed by cardiac troponin I and troponin T in the Ternary troponin complex. Clin Chem. 2017;63(1):343\u201350.","journal-title":"Clin Chem"},{"issue":"12","key":"513_CR119","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/gerona\/glt204","volume":"69","author":"T Zhang","year":"2014","unstructured":"Zhang T, et al. Human Slow Troponin T (TNNT1) Pre-mRNA alternative splicing is an indicator of skeletal muscle response to resistance exercise in older adults. J Gerontol Ser A Biol Sci Med Sci. 2014;69(12):1437\u201347.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"Pt 20","key":"513_CR120","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1242\/jeb.204.20.3457","volume":"204","author":"JH Marden","year":"2001","unstructured":"Marden JH, et al. Alternative splicing, muscle contraction and intraspecific variation: associations between troponin T transcripts, Ca(2+) sensitivity and the force and power output of dragonfly flight muscles during oscillatory contraction. J Exp Biol. 2001;204(Pt 20):3457\u201370.","journal-title":"J Exp Biol"},{"issue":"6","key":"513_CR121","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1006\/jmcc.1998.0698","volume":"30","author":"H Farza","year":"1998","unstructured":"Farza H, et al. Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin T gene. J Mol Cell Cardiol. 1998;30(6):1247\u201353.","journal-title":"J Mol Cell Cardiol"},{"issue":"52","key":"513_CR122","doi-asserted-by":"publisher","first-page":"50275","DOI":"10.1074\/jbc.M206369200","volume":"277","author":"BJ Biesiadecki","year":"2002","unstructured":"Biesiadecki BJ, et al. Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J Biol Chem. 2002;277(52):50275\u201385.","journal-title":"J Biol Chem"},{"key":"513_CR123","doi-asserted-by":"crossref","unstructured":"Sheng JJ, Jin JP. Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review. Front Physiol. 2014;5:165.","DOI":"10.3389\/fphys.2014.00165"},{"issue":"5","key":"513_CR124","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.4049\/jimmunol.179.5.2815","volume":"179","author":"Y Tang","year":"2007","unstructured":"Tang Y, et al. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J Immunol. 2007;179(5):2815\u201323.","journal-title":"J Immunol"},{"key":"513_CR125","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"key":"513_CR126","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3389\/fimmu.2019.02166","volume":"10","author":"PF Zipfel","year":"2019","unstructured":"Zipfel PF, et al. Complement inhibitors in clinical trials for glomerular diseases. Front Immunol. 2019;10:2166.","journal-title":"Front Immunol"},{"key":"513_CR127","doi-asserted-by":"crossref","unstructured":"Albazli K, Kaminski HJ, Howard JF. Complement inhibitor therapy for myasthenia gravis. Front Immunol. 2020;11:917.","DOI":"10.3389\/fimmu.2020.00917"},{"issue":"1\u20132","key":"513_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.07.019","volume":"204","author":"JP Stubgen","year":"2008","unstructured":"Stubgen JP. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders. J Neuroimmunol. 2008;204(1\u20132):1\u201312.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"513_CR129","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","volume":"21","author":"JM Gershoni","year":"2007","unstructured":"Gershoni JM, et al. Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs. 2007;21(3):145\u201356.","journal-title":"BioDrugs"},{"issue":"31","key":"513_CR130","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1073\/pnas.1512561112","volume":"112","author":"VC Casina","year":"2015","unstructured":"Casina VC, et al. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome. Proc Natl Acad Sci U S A. 2015;112(31):9620\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"513_CR131","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/s41598-020-59630-y","volume":"10","author":"V Agnolon","year":"2020","unstructured":"Agnolon V, et al. ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab. Sci Rep. 2020;10(1):3016.","journal-title":"Sci Rep"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-022-00513-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T04:37:18Z","timestamp":1667104638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-022-00513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s11357-022-00513-7","relation":{},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects gave their informed\u00a0consent\u00a0for inclusion before they participated in the IMFIT and SILVER studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Both IMFIT and SILVER studies were approved by the Wake Forest Institutional Review Board and all participants signed informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All study participants consent for publication of data generate from the IMFIT and SILVER studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}